ATE521355T1 - Verwendung eines detergens zur nicht- chirurgischen entfernung von fett - Google Patents

Verwendung eines detergens zur nicht- chirurgischen entfernung von fett

Info

Publication number
ATE521355T1
ATE521355T1 AT05722895T AT05722895T ATE521355T1 AT E521355 T1 ATE521355 T1 AT E521355T1 AT 05722895 T AT05722895 T AT 05722895T AT 05722895 T AT05722895 T AT 05722895T AT E521355 T1 ATE521355 T1 AT E521355T1
Authority
AT
Austria
Prior art keywords
pharmacologically active
fat
detergent
dispersion
detergent compositions
Prior art date
Application number
AT05722895T
Other languages
English (en)
Inventor
Michael Kolodney
Adam Rotunda
Original Assignee
Los Angeles Biomed Res Inst
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34961536&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE521355(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Los Angeles Biomed Res Inst, Univ California filed Critical Los Angeles Biomed Res Inst
Application granted granted Critical
Publication of ATE521355T1 publication Critical patent/ATE521355T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30—Characterized by the absence of a particular group of ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Medicinal Preparation (AREA)
  • Edible Oils And Fats (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
AT05722895T 2004-05-19 2005-02-08 Verwendung eines detergens zur nicht- chirurgischen entfernung von fett ATE521355T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57287904P 2004-05-19 2004-05-19
PCT/US2005/004184 WO2005117900A1 (en) 2004-05-19 2005-02-08 Use of a detergent for the non-surgical removal of fat

Publications (1)

Publication Number Publication Date
ATE521355T1 true ATE521355T1 (de) 2011-09-15

Family

ID=34961536

Family Applications (2)

Application Number Title Priority Date Filing Date
AT05722895T ATE521355T1 (de) 2004-05-19 2005-02-08 Verwendung eines detergens zur nicht- chirurgischen entfernung von fett
AT05751896T ATE518565T1 (de) 2004-05-19 2005-05-19 Verfahren und relevante zusammensetzungen zur reduzierung von fett

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT05751896T ATE518565T1 (de) 2004-05-19 2005-05-19 Verfahren und relevante zusammensetzungen zur reduzierung von fett

Country Status (25)

Country Link
US (3) US7622130B2 (de)
EP (8) EP2422789B1 (de)
JP (2) JP5060295B2 (de)
KR (1) KR101217497B1 (de)
CN (2) CN105233287A (de)
AT (2) ATE521355T1 (de)
AU (1) AU2005245002C1 (de)
CA (1) CA2567298C (de)
CY (4) CY1111974T1 (de)
DK (5) DK2422789T3 (de)
ES (5) ES2660172T3 (de)
FI (1) FI3692995T3 (de)
FR (2) FR20C1048I2 (de)
HK (2) HK1099521A1 (de)
HU (5) HUE038247T2 (de)
IL (2) IL179008A (de)
LT (3) LT2422789T (de)
MX (1) MXPA06013437A (de)
NL (1) NL301229I2 (de)
NZ (2) NZ551000A (de)
PL (4) PL2422789T3 (de)
PT (5) PT2422789T (de)
SI (4) SI2422789T1 (de)
TR (1) TR201802446T4 (de)
WO (2) WO2005117900A1 (de)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2422789T1 (en) 2004-05-19 2018-07-31 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center An injectable composition comprising sodium deoxycholate
US7754230B2 (en) * 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
US20060127468A1 (en) * 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
US20060074057A1 (en) * 2004-10-04 2006-04-06 Eric Marchewitz Use of chenodeoxycholic acid for reducing adipose tissue
JP4646669B2 (ja) * 2005-03-30 2011-03-09 キヤノン株式会社 吐出用液体、吐出方法、液滴化方法、カートリッジ及び吐出装置
US20060222695A1 (en) * 2005-04-01 2006-10-05 Filiberto Zadini Deoxycholic acid liposome-based dermatological topical preparation
US20070071706A1 (en) * 2005-09-28 2007-03-29 Filiberto Zadini Lipodissolving dermatological topical preparation
US8304383B2 (en) 2005-11-22 2012-11-06 Atheronova Operations, Inc. Dissolution of arterial plaque
US20090035348A1 (en) * 2005-11-22 2009-02-05 Z & Z Medical Holdings, Inc. Dissolution of arterial plaque
US7676604B2 (en) * 2005-11-22 2010-03-09 Intel Corporation Task context direct indexing in a protocol engine
US20110082124A1 (en) * 2006-02-23 2011-04-07 Kythera Biopharmaceuticals, Inc. Detergent compositions for treatment of lipomas and other conditions
WO2008008468A2 (en) * 2006-07-14 2008-01-17 Duncan Diane I Compositions and methods for fat reduction
WO2008066775A2 (en) * 2006-11-22 2008-06-05 Duncan Diane I Compositions and methods to reduce fat and retract skin
DE102007015701A1 (de) * 2007-03-19 2008-09-25 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Neue pharmazeutische Zusammensetzungen für die Lipolyse und Verfahren zu deren Herstellung
US8057381B2 (en) * 2007-04-16 2011-11-15 Allen Iii William F Method and implant material for treatment of urinary incontinence
MY160040A (en) 2007-06-19 2017-02-15 Kythera Biopharmaceuticals Inc Synthetic bile acid composition, method and preparation
JOP20180077A1 (ar) 2007-06-19 2019-01-30 Kythera Biopharmaceuticals Inc تركيبات وطرق لحمض صفراوي تخليقي
US8242294B2 (en) 2007-06-19 2012-08-14 Kythera Biopharmaceuticals, Inc. Synthetic bile acid compositions and methods
US20080318870A1 (en) 2007-06-19 2008-12-25 Kythera Biopharmaceuticals, Inc. Synthetic bile acid compositions and methods
US7943187B2 (en) 2008-05-23 2011-05-17 Bakr Rabie Paeoniflorin preparations and uses thereof for fat reduction
FR2937554B1 (fr) * 2008-10-27 2010-11-12 Yves Crassas Solutions salines aqueuses pour la destruction de tissus graisseux
BRPI1007812B1 (pt) * 2009-03-02 2017-09-26 Doris Maria Hexsel Lipoatrofia cosmetic medicinal
US10213441B2 (en) 2009-03-02 2019-02-26 Doris Hexsel Medicinal cosmetic lipoatrophy
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
EA201200428A1 (ru) * 2009-10-09 2013-02-28 Атеронова Оперэйшионс, Инк. Композиция и способ для лечения ожирения
GB2480632A (en) 2010-05-25 2011-11-30 Kythera Biopharmaceuticals Inc Preparation of 12-keto and 12-alpha-hydroxy steroids
WO2012021133A1 (en) 2010-08-12 2012-02-16 Kythera Biopharmaceuticals, Inc. Synthetic bile acid compositions and methods
WO2012112940A1 (en) 2011-02-18 2012-08-23 Kythera Biopharmaceuticals, Inc. Treatment of submental fat
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
US20130085125A1 (en) 2011-06-16 2013-04-04 Kythera Biopharmaceuticals, Inc. Methods for the synthesis and purification of deoxycholic acid
EA034320B1 (ru) * 2011-08-23 2020-01-28 Китера Биофармасьютикалз, Инк. Композиции дезоксихолата натрия
WO2013028177A1 (en) * 2011-08-23 2013-02-28 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
PT3305298T (pt) 2011-08-23 2019-07-29 Allergan Sales Llc Formulação do ácido desoxicólico e seus sais
MX2014004792A (es) * 2011-10-21 2015-08-14 Auxilium Int Holdings Inc Metodo de tratamiento o reduccion de efp.
US8426471B1 (en) 2011-12-19 2013-04-23 Topokine Therapeutics, Inc. Methods and compositions for reducing body fat and adipocytes
EP2793813A1 (de) 2011-12-21 2014-10-29 Motolese, Pasquale Kosmetische zusammensetzung und ihre verwendung bei der behandlung von lipodystrophien
ES2740499T3 (es) 2012-01-12 2020-02-05 Endo Global Ventures Enzima de Clostridium histolyticum
WO2014081941A1 (en) 2012-11-21 2014-05-30 Topokine Therapeutics, Inc. Methods and compositions for locally increasing body fat
NO2753788T3 (de) 2013-05-10 2018-06-16
WO2014186504A1 (en) 2013-05-15 2014-11-20 Topokine Therapeutics, Inc. Methods and compositions for topical delivery of prostaglandins to subcutaneous fat
WO2015179282A1 (en) 2014-05-20 2015-11-26 Topokine Therapeutics, Inc. Topical compositions comprising a thiazolidinedione
US20170196891A1 (en) * 2014-06-01 2017-07-13 Galmed Research And Development Ltd. Fatty acid bile acid conjugates for treatment of lipodystrophy
SG11201610228RA (en) * 2014-06-27 2017-01-27 Medytox Inc Methods and compositions of bile acids and salts for reduction of fat
WO2015200425A1 (en) 2014-06-27 2015-12-30 Topokine Therapeutics, Inc. Topical dosage regimen
US9687455B2 (en) 2014-08-14 2017-06-27 John Daniel Dobak Sodium tetradecyl sulfate formulations for treatment of adipose tissue
EP3915542B1 (de) 2014-12-23 2023-11-22 Dyve Biosciences, Inc. Formulierungen zur transdermalen verabreichung
US9351945B1 (en) 2015-02-27 2016-05-31 John Daniel Dobak, III Reduction of adipose tissue
US9925170B2 (en) 2015-10-01 2018-03-27 Kythera Biopharmaceuticals, Inc. Methods of adipolysis and compositions useful therein
CA3003746A1 (en) * 2015-11-04 2017-05-11 Kythera Biopharmaceuticals, Inc. Treatments of accumulated fat with deoxycholic acid and salts thereof
JP6219430B2 (ja) * 2016-03-18 2017-10-25 キテラ バイオファーマシューティカルズ，インコーポレイテッド デオキシコール酸およびその塩類の製剤
US11117925B2 (en) 2016-06-06 2021-09-14 Bionice, S.L.U. Methods for the preparation of deoxycholic acid, and intermediates useful in the preparation of deoxycholic acid
KR101841193B1 (ko) * 2016-09-22 2018-03-22 이경락 저장성 지방 분해 조성물 및 그의 제조 방법
US20180078621A1 (en) * 2016-09-22 2018-03-22 Kyoung Lack Lee Composition for hypotonic lipolysis and manufacturing method thereof
CN115969318A (zh) 2017-03-01 2023-04-18 恩多风投有限公司 用于评估和治疗橘皮组织的装置和方法
MX2019011574A (es) 2017-03-28 2019-12-19 Endo Ventures Ltd Método mejorado para producir aplicaciones relacionadas con la colagenasa.
KR101887586B1 (ko) 2017-04-21 2018-08-10 이기택 통증과 부종 그리고 부작용이 없는 국소지방 감소용 주사제 조성물 및 이의 제조방법
KR102093872B1 (ko) * 2017-07-03 2020-03-27 진호성 지방제거용 주사제 조성물 및 이의 제조방법
CN111328332B (zh) * 2017-08-03 2023-01-24 玫帝托克斯股份有限公司 用于制备胆汁酸类的方法
JP6356329B2 (ja) * 2017-09-27 2018-07-11 キテラ バイオファーマシューティカルズ，インコーポレイテッド デオキシコール酸およびその塩類の製剤
WO2019081586A1 (en) 2017-10-24 2019-05-02 Bionice, S.L.U. PREPARATION OF DEOXYCHOLIC ACID
CN110302082A (zh) * 2018-03-27 2019-10-08 上海同柏生物科技有限公司 用于减少身体脂肪沉积的技术及组合物制剂与应用
JP6594486B2 (ja) * 2018-06-13 2019-10-23 キテラ バイオファーマシューティカルズ，インコーポレイテッド デオキシコール酸およびその塩類の製剤
KR102116238B1 (ko) * 2018-08-28 2020-05-28 이경락 저장성 지방 분해 조성물 및 그의 제조 방법
EP3713551B1 (de) 2018-10-16 2023-06-07 Polithera, Inc. Zusammensetzungen auf der basis von alkohol und verwendungen davon
US11439659B2 (en) * 2018-12-03 2022-09-13 The Regents Of The University Of California Methods and compositions to prevent and treat inflammation and allergic reactions
KR102172439B1 (ko) * 2018-12-05 2020-10-30 송미희 지방 분해용 조성물 및 이를 포함하는 주사제 조성물
KR102064864B1 (ko) 2019-02-08 2020-01-10 (주)제테마 국소 주사용 조성물
KR102111346B1 (ko) 2019-08-20 2020-05-22 아영창 침전으로부터 안정한 소듐디옥시콜레이트를 포함하는 수용액상 조성물
WO2023287261A1 (ko) 2021-07-16 2023-01-19 주식회사 스카이테라퓨틱스 담즙산 또는 담즙산 염의 분자 회합체를 포함하는 화장료 조성물
CA3220724A1 (en) * 2022-07-05 2024-01-05 Yongyu Chew Injectable composition comprising cytolytic compound in gel, gel-forming solution or gel-forming suspension for reduction of fat

Family Cites Families (105)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4113882A (en) * 1974-10-21 1978-09-12 Yamanouchi Pharmaceutical Co., Ltd. Stabilized oral prostaglandin formulation and the process for the preparation thereof
IT1202370B (it) * 1976-07-12 1989-02-09 Hoffmann La Roche Soluzioni inietabili in cui l'atti vita' emolitica degli agenti di formazione di micelle naturali e' evitata mediante l'aggiunta di lipoidi e relativi prodotti
US4117121A (en) * 1977-04-22 1978-09-26 Hoffmann-La Roche Inc. Method of increasing bile flow and decreasing lipid levels
IT8167097A0 (it) * 1981-01-26 1981-01-26 Unilever Nv Composizione cosmetica per il trattamento della pelle o dei capelli
US5288498A (en) * 1985-05-01 1994-02-22 University Of Utah Research Foundation Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments
GB8417895D0 (en) 1984-07-13 1984-08-15 Marples B A Pharmaceutical anti-fungal composition
JPS61158995A (ja) * 1984-12-28 1986-07-18 Takara Shironaga 脂肪肝，胆石，胃粘膜障害発生の予防薬または治療薬
US4866044A (en) * 1985-07-09 1989-09-12 Takeda Chemical Industries, Ltd. Solubilized composition of poorly-soluble pharmaceutical product
IT1213453B (it) * 1985-08-02 1989-12-20 Merz & Co Gmbh & Co Composizione farmaceutica.
US5326562A (en) * 1986-06-03 1994-07-05 Incyte Pharmaceuticals, Inc. Pharmaceutical dosage unit for treating inflammation comprising protease nexin-I
US4952411A (en) 1987-02-25 1990-08-28 Trustees Of Columbia University In The City Of New York Method of inhibiting the transmission of AIDS virus
US5690954A (en) * 1987-05-22 1997-11-25 Danbiosyst Uk Limited Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material
US4994439A (en) * 1989-01-19 1991-02-19 California Biotechnology Inc. Transmembrane formulations for drug administration
IL89530A0 (en) * 1989-03-08 1989-09-10 Jeffrey J Feigenbaum Compositions containing forskolin
GB8909022D0 (en) 1989-04-20 1989-06-07 Cortecs Ltd Pharmaceutical compositions
EP0408174A1 (de) 1989-07-12 1991-01-16 Warner-Lambert Company Hexahydro-5-pyrimidinamin Verbindungen enthaltende antiseptische Zusammensetzung
AU6461090A (en) 1989-10-30 1991-05-02 Abbott Laboratories Injectable formulation for lipophilic drugs
US5085864A (en) * 1989-10-30 1992-02-04 Abbott Laboratories Injectable formulation for lipophilic drugs
CA2033725C (en) 1990-01-24 2001-05-29 Folker Pittrof Pharmaceutical and cosmetic compositions containing a salt of cholanic acid
US6120805A (en) * 1990-04-06 2000-09-19 Rhone-Poulenc Rorer Sa Microspheres, process for their preparation and their use
JP3032315B2 (ja) * 1991-01-14 2000-04-17 健二 片桐 脂肪肝治療剤
GB9212511D0 (en) * 1992-06-12 1992-07-22 Cortecs Ltd Pharmaceutical compositions
US5674855A (en) 1992-08-12 1997-10-07 The Rogosin Institute Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions
US5344822A (en) 1992-08-12 1994-09-06 The Rogosin Institute Methods useful in endotoxin prophylaxis and therapy
US6663885B1 (en) * 1993-03-15 2003-12-16 A. Natterman & Cie Gmbh Aqueous liposome system and a method for the preparation of such a liposome system
GB9320597D0 (en) 1993-10-06 1993-11-24 Proteus Molecular Design Improvements in and realting to vaccines
US5395545A (en) * 1993-10-21 1995-03-07 Akzo N.V. Cleaning solution for automated analyzers
US6932962B1 (en) 1994-12-22 2005-08-23 Astrazeneca Ab Aerosol drug formulations containing hydrofluoroalkanes and alkyl saccharides
JP2740153B2 (ja) 1995-03-07 1998-04-15 エフ・ホフマン−ラ ロシユ アーゲー 混合ミセル
US5616342A (en) 1995-04-11 1997-04-01 Pdt, Inc. Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof
US5759445A (en) 1995-05-24 1998-06-02 Matsushita Electric Industrial Co., Ltd. Lipid-dispersed solution and process for producing the same
US20040101569A1 (en) 1996-05-16 2004-05-27 Lorus Therapeutics Inc. Immunomodulating compositions from bile
BR9710289A (pt) 1996-07-11 1999-08-17 Farmarc Nederland Bv Composi-Æo farmac-utica contendo sal cido de adi-Æo de medicamento b sico
US5952392A (en) * 1996-09-17 1999-09-14 Avanir Pharmaceuticals Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition
US7351421B2 (en) 1996-11-05 2008-04-01 Hsing-Wen Sung Drug-eluting stent having collagen drug carrier chemically treated with genipin
CA2282411A1 (en) 1997-02-27 1998-09-03 Nippon Shinyaku Co., Ltd. Fat emulsion for oral administration
US5891083A (en) 1997-04-22 1999-04-06 Capella; Rafael F. Suction lipolysis
US20020107291A1 (en) 1997-05-26 2002-08-08 Vincenzo De Tommaso Clear, injectable formulation of an anesthetic compound
US6416779B1 (en) * 1997-06-11 2002-07-09 Umd, Inc. Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
US6197327B1 (en) * 1997-06-11 2001-03-06 Umd, Inc. Device and method for treatment of dysmenorrhea
AU8067198A (en) 1997-06-13 1998-12-30 University Of Nebraska Board Of Regents Compositions for delivery of biological agents and methods for the preparation thereof
US6638621B2 (en) * 2000-08-16 2003-10-28 Lyotropic Therapeutics, Inc. Coated particles, methods of making and using
US6054421A (en) * 1997-09-23 2000-04-25 Scimed Life Systems, Inc. Medical emulsion lubricant
US6281175B1 (en) * 1997-09-23 2001-08-28 Scimed Life Systems, Inc. Medical emulsion for lubrication and delivery of drugs
US6350458B1 (en) * 1998-02-10 2002-02-26 Generex Pharmaceuticals Incorporated Mixed micellar drug deliver system and method of preparation
US6221378B1 (en) * 1998-02-10 2001-04-24 Generex Pharmaceuticals Incorporated Mixed micellar delivery system and method of preparation
US7303768B2 (en) 1998-07-24 2007-12-04 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
WO2000004875A2 (en) * 1998-07-24 2000-02-03 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
US20050158408A1 (en) 1998-07-24 2005-07-21 Yoo Seo H. Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof
TW570805B (en) * 1998-09-01 2004-01-11 Hoffmann La Roche Water-soluble pharmaceutical composition in an ionic complex
SE9803240D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
US6417179B1 (en) 1998-10-13 2002-07-09 Craig G. Burkhart Ear wax solution
US6375975B1 (en) * 1998-12-21 2002-04-23 Generex Pharmaceuticals Incorporated Pharmaceutical compositions for buccal and pulmonary application
US6451286B1 (en) * 1998-12-21 2002-09-17 Generex Pharmaceuticals Incorporated Pharmaceutical compositions for buccal and pulmonary administration comprising an alkali metal alkyl sulfate and at least three micelle-forming compounds
US6849263B2 (en) * 1998-12-21 2005-02-01 Generex Pharmaceutical Incorporated Pharmaceutical compositions for buccal delivery of pain relief medications
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
DK1582204T3 (da) 1999-03-03 2013-11-04 Lilly Co Eli Echinocandin-farmaceutiske formuleringer, der indeholder miceldannende overfladeaktive stoffer
US6350432B1 (en) * 1999-03-19 2002-02-26 Generex Pharmaceuticals Incorporated Pressurized container having an aerosolized pharmaceutical composition
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
US6489312B1 (en) * 1999-06-15 2002-12-03 Medimmune Oncology, Inc. Pharmaceutical formulations comprising aminoalkyl phosphorothioates
US6225343B1 (en) * 1999-06-16 2001-05-01 Nastech Pharmaceutical Company, Inc. Compositions and methods comprising morphine gluconate
WO2001056547A2 (en) * 2000-02-04 2001-08-09 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
GB0009773D0 (en) * 2000-04-19 2000-06-07 Univ Cardiff Particulate composition
FR2813189B1 (fr) 2000-08-31 2003-02-28 Oreal Creme cosmetique moussante pour le traitement des peaux grasses
JP2004508550A (ja) * 2000-09-08 2004-03-18 ダウ　グローバル　テクノロジーズ　インコーポレーテッド 逐次検知イオンクロマトグラフィー
DK1343492T3 (da) 2000-11-22 2006-03-06 Rxkinetix Inc Behandling af mucositis
WO2002047694A1 (en) * 2000-12-13 2002-06-20 Feher Janos Pharmaceutical compositions for treatment of digestive disorders and associated diseases
US7037528B2 (en) * 2000-12-22 2006-05-02 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US20040022862A1 (en) * 2000-12-22 2004-02-05 Kipp James E. Method for preparing small particles
US20030072807A1 (en) * 2000-12-22 2003-04-17 Wong Joseph Chung-Tak Solid particulate antifungal compositions for pharmaceutical use
US20030053956A1 (en) 2001-01-24 2003-03-20 Thomas Hofmann Alkylaryl polyether alcohol polymers for treatment and prophylaxis of snoring, sleep apnea, sudden infant death syndrome and for improvement of nasal breathing
SE0100901D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab New composition
JP2004524368A (ja) 2001-03-27 2004-08-12 フェアーズ ファーマシューティカル リサーチ エヌ．ヴェー． 低い水溶性を有する生物学的に活性な化合物を可溶化するための方法および組成物
CA2446060A1 (en) * 2001-05-07 2002-11-14 Corium International Compositions and delivery systems for administration of a local anesthetic agent
AU2002313236B2 (en) 2001-06-14 2007-07-26 Otsuka Pharmaceutical Co., Ltd. Medicinal compositions
US20030083286A1 (en) 2001-08-22 2003-05-01 Ching-Leou Teng Bioadhesive compositions and methods for enhanced intestinal drug absorption
US7112340B2 (en) * 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
US6713470B2 (en) * 2002-01-22 2004-03-30 Ml Laboratories Plc Method of treatment
GB0207529D0 (en) 2002-04-02 2002-05-08 Norbrook Lab Ltd Injectable veterinary composition for small animals
AU2003234452A1 (en) 2002-05-06 2003-11-11 Elan Pharma International Ltd. Nanoparticulate nystatin formulations
MXPA04011584A (es) * 2002-05-23 2005-03-31 Umd Inc Composiciones y metodo para la administracion y crioproteccion de drogas transmucosales.
US20040220283A1 (en) * 2002-07-29 2004-11-04 Transform Pharmaceuticals, Inc. Aqueous 2,6-diisopropylphenol pharmaceutical compositions
KR101145692B1 (ko) 2002-07-29 2012-05-25 트렌스폼 파마수티컬스 인코퍼레이티드 수성 2,6-디이소프로필페놀 약제학적 조성물
US20050163821A1 (en) 2002-08-02 2005-07-28 Hsing-Wen Sung Drug-eluting Biodegradable Stent and Delivery Means
US20050019404A1 (en) 2003-06-30 2005-01-27 Hsing-Wen Sung Drug-eluting biodegradable stent
KR100482269B1 (ko) * 2002-10-08 2005-04-14 센츄론(주) 2,6-디이소프로필페놀을 활성성분으로 하는 수용액상의마취용 주사제 및 그 제조방법
US20040171691A1 (en) 2002-10-29 2004-09-02 Transform Pharmaceuticals, Inc. Propofol with cysteine
US20050079228A1 (en) * 2003-05-30 2005-04-14 Ashish Jaiswal Clear, stable topical compositions of clarithromycin and processes for their preparation
CN1894259A (zh) 2003-08-22 2007-01-10 活跃生物工艺学公司 利福霉素类似物及其应用
US20050089555A1 (en) 2003-10-24 2005-04-28 Aventis Pharma Deutschland Gmbh Medicinal targeted local lipolysis
DE10349979B4 (de) * 2003-10-24 2006-05-18 Sanofi-Aventis Deutschland Gmbh Medikamentöse gezielte lokale Lipolyse
US20050143347A1 (en) * 2003-12-22 2005-06-30 Aventis Pharma Deutschland Gmbh Medicinal lipolysis of accumulations of fat
DE10361067A1 (de) 2003-12-22 2005-07-14 Aventis Pharma Deutschland Gmbh Medikamentöse Lipolyse von Fettansammlungen
EP1699432A2 (de) * 2003-12-22 2006-09-13 Aventis Pharmaceuticals, Inc. Injizierbare phosphatidylcholin-präparate
KR100638041B1 (ko) 2003-12-24 2006-10-23 주식회사 삼양사 수용성 약물의 경구투여용 나노입자 조성물 및 그의제조방법
US7754230B2 (en) 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
SI2422789T1 (en) * 2004-05-19 2018-07-31 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center An injectable composition comprising sodium deoxycholate
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
FR2870741B1 (fr) 2004-05-25 2008-03-14 Coletica Sa Phase lamellaires hydratees ou liposomes, contenant une monoamine grasse ou un polymere cationique favorisant la penetration intercellulaire, et composition cosmetique ou pharmaceutique la contenant.
JP4773430B2 (ja) 2004-06-03 2011-09-14 ブラッコ・リサーチ・ソシエテ・アノニム 治療および／または診断用途のためのリポソーム集合体
US20050287199A1 (en) 2004-06-28 2005-12-29 Teresa Ann Denney Therapeutic micro nutrient composition for lipolysis and drug delivery
WO2006007675A1 (en) * 2004-07-20 2006-01-26 Libbs Farmacêutica Ltda. Cholic acid and/or its derivatives for the reduction of localized fat in the human body
US20060074057A1 (en) * 2004-10-04 2006-04-06 Eric Marchewitz Use of chenodeoxycholic acid for reducing adipose tissue
US20060222695A1 (en) * 2005-04-01 2006-10-05 Filiberto Zadini Deoxycholic acid liposome-based dermatological topical preparation

Also Published As

Publication number Publication date
EP2572718A1 (de) 2013-03-27
PT1758590E (pt) 2011-11-15
NL301229I2 (nl) 2023-11-23
US20060154906A1 (en) 2006-07-13
PT2380576T (pt) 2020-06-17
CA2567298A1 (en) 2005-12-01
SI2380576T1 (sl) 2020-10-30
PL2422789T3 (pl) 2018-09-28
ATE518565T1 (de) 2011-08-15
DK2380576T3 (da) 2020-06-08
AU2005245002A1 (en) 2005-12-01
TR201802446T4 (tr) 2018-03-21
JP5060295B2 (ja) 2012-10-31
EP1758590A1 (de) 2007-03-07
HUE061343T2 (hu) 2023-06-28
US8298556B2 (en) 2012-10-30
MXPA06013437A (es) 2007-03-23
US20100048527A1 (en) 2010-02-25
FR20C1048I1 (fr) 2020-11-27
JP2012176966A (ja) 2012-09-13
CY1120146T1 (el) 2018-12-12
DK3692995T3 (da) 2023-01-30
CA2567298C (en) 2013-07-09
AU2005245002B8 (en) 2011-12-15
EP2422789B1 (de) 2017-11-22
HK1099521A1 (en) 2007-08-17
CY2018008I1 (el) 2020-05-29
ES2795749T3 (es) 2020-11-24
CN101018553A (zh) 2007-08-15
EP2380576A3 (de) 2012-02-22
WO2005117900A1 (en) 2005-12-15
FR20C1048I2 (fr) 2024-03-08
EP2380576B1 (de) 2020-04-08
EP1758590B1 (de) 2011-08-24
DK2422789T3 (en) 2018-02-26
HUS2300016I1 (hu) 2023-05-28
HUS1700004I1 (hu) 2017-02-28
IL179008A0 (en) 2007-05-15
SI1758590T1 (sl) 2012-03-30
PT3692995T (pt) 2023-02-06
ES2372416T3 (es) 2012-01-19
LTPA2017006I1 (lt) 2017-03-27
DK1758590T3 (da) 2011-11-21
KR20070024527A (ko) 2007-03-02
DK1748780T3 (da) 2011-11-21
PL1758590T3 (pl) 2012-03-30
ES2939383T3 (es) 2023-04-21
IL207126A (en) 2014-02-27
EP3424508B1 (de) 2021-05-05
PL1748780T3 (pl) 2012-03-30
SI1748780T1 (sl) 2012-02-29
EP2422789A1 (de) 2012-02-29
CY1111974T1 (el) 2015-11-04
US7622130B2 (en) 2009-11-24
NZ551000A (en) 2010-10-29
ES2372499T3 (es) 2012-01-20
IL207126A0 (en) 2010-12-30
HK1101062A1 (en) 2007-10-05
KR101217497B1 (ko) 2013-01-03
JP2007538104A (ja) 2007-12-27
PT1748780E (pt) 2011-11-10
CN101018553B (zh) 2015-11-25
EP2550968A1 (de) 2013-01-30
KR101217497B9 (ko) 2022-01-11
SI2422789T1 (en) 2018-07-31
FI3692995T3 (fi) 2023-03-02
LT2380576T (lt) 2020-08-10
NZ586818A (en) 2012-09-28
PT2422789T (pt) 2018-02-26
HUE049990T2 (hu) 2020-11-30
AU2005245002B2 (en) 2011-07-07
AU2005245002C1 (en) 2011-12-15
EP3692995B1 (de) 2022-11-02
IL179008A (en) 2010-12-30
CY1112204T1 (el) 2015-12-09
PL3692995T3 (pl) 2023-05-22
EP3424508A1 (de) 2019-01-09
EP3692995A1 (de) 2020-08-12
HUE038247T2 (hu) 2018-10-29
CN105233287A (zh) 2016-01-13
EP1748780B1 (de) 2011-08-03
EP2380576A2 (de) 2011-10-26
LT2422789T (lt) 2018-03-12
EP1748780A1 (de) 2007-02-07
WO2005112942A1 (en) 2005-12-01
FR23C1018I1 (fr) 2023-06-23
ES2660172T3 (es) 2018-03-21
US20050261258A1 (en) 2005-11-24

Similar Documents

Publication Publication Date Title
ATE521355T1 (de) Verwendung eines detergens zur nicht- chirurgischen entfernung von fett
SG161202A1 (en) Methods and related compositions for reduction of fat and skin tightening
MY128963A (en) Treatment and composition for achieving skin anti-aging benefits by corneum protease activation
EP2591789A3 (de) Haftende zellen von fett- oder plazenta-gewebe und ihre verwendung in der therapie
MA30978B1 (fr) Gel d'acide hyaluronique pour injection intradermique
Schmidt et al. The course of the temporal branch of the facial nerve in the periorbital region
WO2004019884A3 (en) Agents and methods for enhancing bone formation
MY147643A (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
WO2003103614A3 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF OEDEMATUS FIBROSCLEREUS PANNICULOPATHY
Benito-Ruiz Buttock and Hip Enhancement with Implants
RU2000106738A (ru) Способ контурной пластики височной зоны и наружного края орбиты у пациентов с постлучевой атрофией тканей орбиты
UA36252A (uk) Спосіб визначення індивідуальності хворого для вибору адекватної гомеопатичної терапії

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1758590

Country of ref document: EP